About Multiple Sclerosis

Multiple Sclerosis is a chronic, incurable, and unpredictable disease of the central nervous system (the brain, optic nerves, and spinal cord). MS is characterized by the...

Support Our Work (pictured above: Tisch MSRCNY Research Team)

The Tisch MS Research Center of New York is dedicated to finding the cause of and cure for multiple sclerosis. Tisch MS focuses on translational research, bringing...

Facilities

The Tisch MS Research Center is equipped with the latest in research equipment and technology in order to conduct cutting-edge research for the benefit of people with MS...

Research

At Tisch MS we have several ongoing research projects.  Browse this section to learn more about each project.

FDA Approves Neural Stem Cell Trial

(pictured above Dr. Saud A. Sadiq and Dr. Violaine K. Harris)

Repair Strategies in MS

There are no existing therapies that are capable of repairing the myelin and nerve damage that exist in MS. Dr. Harris and her team focused on adult stem cells from the...

The Tisch MS Research Center of New York is dedicated to finding the cause and cure of multiple sclerosis

Tisch MS News

Two studies from the Tisch MS Center were selected by the American Academy of Neurology (AAN) Science Committee to be highlighted as a significant advance based on animal research. Congratulations to first authors Ruth-Anne Langan (Dr. Violaine Harris' group) and Dr. Marwan Alahiri (Dr. Ying Liu's group) for being selected. 

The stem cell research division of the Tisch MS Research Center of New York is pleased to announce the completed enrollment of 20 patients to participate in the phase I clinical trial investigating the safety and efficacy of autologous, mesenchymal stem cell-derived neural progenitors (MSC-NPs) for the treatment of multiple sclerosis. We are no longer recruiting for this study. Interim results of this clinical trial will be presented at upcoming scientific conferences and simultaneously...

Real Time Analytics